Praecis Pharmaceuticals (MM) News - PRCS

GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS

PHILADELPHIA and LONDON, Feb. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) announced today the successful completion of the...

GlaxoSmithKline Extends Subsequent Offering Period By One Day

PHILADELPHIA, Feb. 15 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it is extending the subsequent offering...

GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period

PHILADELPHIA and LONDON, Feb. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) announced today the expiration of the initial offering...

GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS

LONDON, Jan. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) (GSK) announced today that Pilgrim Acquisition Corporation, a wholly...

PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced consolidated financial results for the three and nine months...

PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it is presenting interim clinical data from an ongoing...

PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today announced that it will report Third Quarter 2006 financial results on...

PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it received the Cerep Award for Research with the...

PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it is presenting preclinical data on its investigational...

PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced consolidated financial results for the three and six months ended June 30...

PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today announced that it will report Second Quarter 2006 financial results on Friday, August...

PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today reported that it will not be able to enter into by June 30, 2006 a license or sale...

PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced consolidated financial results for the three months ended March 31, 2006. ?...

PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006

PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today announced that it will report First Quarter 2006 financial results on Friday, May 5...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Praecis Pharmaceuticals (MM) (PRCS)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

PRCS News

GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS

GlaxoSmithKline Extends Subsequent Offering Period By One Day

GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period

GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS

PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium

PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006

PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24

PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458

PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006

PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna

PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006

PRCS Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Praecis Pharmaceuticals (MM) (PRCS) News

Praecis Pharmaceuticals (MM) (PRCS)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

PRCS News

GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS

GlaxoSmithKline Extends Subsequent Offering Period By One Day

GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period

GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS

PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium

PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006

PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24

PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458

PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006

PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna

PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results

PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006

PRCS Discussion

Your Recent History